0001562180-22-006259.txt : 20220822 0001562180-22-006259.hdr.sgml : 20220822 20220822190032 ACCESSION NUMBER: 0001562180-22-006259 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220819 FILED AS OF DATE: 20220822 DATE AS OF CHANGE: 20220822 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bailey Gregory CENTRAL INDEX KEY: 0001329505 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38080 FILM NUMBER: 221184817 MAIL ADDRESS: STREET 1: 4 A CHESHAM STREET CITY: LONDON STATE: X0 ZIP: SW1X8DT ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd. CENTRAL INDEX KEY: 0001689813 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 203-404-0410 MAIL ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2022-08-19 false 0001689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN 0001329505 Bailey Gregory C/O BIOHAVEN PHARMACEUTICALS, INC. 215 CHURCH STREET NEW HAVEN CT 06510 true false false false Common Stock 2022-08-19 4 P false 38000.00 148.0441 A 2583658.00 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $147.98 - $148.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. /s/ George Clark, Attorney-in-Fact 2022-08-22